Harry Jin

Harry Jin, PhD, MPH, currently serves as Associate Director - RWE Product Lead at Gilead Sciences, where responsibilities include developing and executing real-world evidence (RWE) strategies aligned with clinical development plans. Prior to this role, Harry held various positions at TriNetX, including Director of Real-World Evidence and Consulting, and also worked as an Epidemiology Consultant at EpiMetrix, Inc. with expertise in analyzing real-world and registry data for pharmaceutical clients. Academic experience includes a Graduate Research and Teaching Assistant position at Brown University focused on HIV clinical trials, alongside previous roles at Gilead Sciences as a Statistical Programmer II, and as a Data Manager/Analyst at the San Francisco Department of Public Health. Educational qualifications include a PhD in Epidemiology from Brown University and a Master of Public Health from Yale School of Public Health.